Unibody core-shell smart polymer as a theranostic nanoparticle for drug delivery and MR imaging

Biomaterials. 2015 Jan:37:436-46. doi: 10.1016/j.biomaterials.2014.10.006. Epub 2014 Oct 23.

Abstract

Developing novel multifunctional nanoparticles (NPs) with robust preparation, low cost, high stability, and flexible functionalizability is highly desirable. This study provides an innovative platform, termed unibody core-shell (UCS), for this purpose. UCS is comprised of two covalent-bonded polymers differed only by the functional groups at the core and the shell. By conjugating Gd(3+) at the stable core and encapsulating doxorubicin (Dox) at the shell in a pH-sensitive manner, we developed a theranostic NPs (UCS-Gd-Dox) that achieved a selective drug release (75% difference between pH 7.4 and 5.5) and MR imaging (r1 = 0.9 and 14.5 mm(-1) s(-1) at pH 7.4 and 5.5, respectively). The anti-cancer effect of UCS-Gd-Dox is significantly better than free Dox in tumor-bearing mouse models, presumably due to enhanced permeability and retention effect and pH-triggered release. To the best of our knowledge, this is the simplest approach to obtain the theranostic NPs with Gd-conjugation and Dox doping.

Keywords: Core–shell; Drug delivery; Magnetic resonance imaging (MRI); Nanoparticle.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Drug Delivery Systems*
  • Female
  • Gadolinium
  • HeLa Cells
  • Humans
  • Hydrogen-Ion Concentration
  • Magnetic Resonance Imaging*
  • Mice
  • Mice, Inbred NOD
  • Mice, SCID
  • NIH 3T3 Cells
  • Nanoparticles / therapeutic use*
  • Nanoparticles / ultrastructure
  • Polymers / therapeutic use*
  • Time Factors

Substances

  • Polymers
  • Gadolinium